Summary：Novanta Set to Shine at CJS Securities' Prestigious Summer Conference 2026BOSTON — Novanta Inc. (Nas

Novanta Set to Shine at CJS Securities' Prestigious Summer Conference 2026

BOSTON — Novanta Inc. (Nasdaq: NOVT), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Chuck Ravetto, Chief Operating Officer, are scheduled to participate in the highly anticipated CJS Securities' Summer Conference 2026. This event is poised to be a significant milestone for Novanta, offering a platform to showcase its innovative solutions and strategic growth plans to a distinguished audience of investors and industry leaders.

The CJS Securities' Summer Conference is renowned for bringing together top executives from cutting-edge companies, providing a unique opportunity for Novanta's leadership to engage with key stakeholders and share the company's vision for the future. With its robust portfolio of precision technology components and sub-systems, Novanta is well-positioned to captivate the attention of conference attendees. The company's expertise in delivering customized solutions has been instrumental in driving its success across various high-growth markets, including medical technology and advanced industrial technologies.

Industry analysis suggests that Novanta's participation in the CJS Securities' Summer Conference 2026 is timely, given the increasing demand for precision technology in the medical and industrial sectors. As manufacturers continue to seek innovative solutions to enhance product performance and efficiency, companies like Novanta are poised to benefit from this trend. The company's diversified revenue streams and commitment to R&D are expected to be key discussion points during the conference, underscoring its potential for long-term growth.

Looking ahead, Novanta's presence at the CJS Securities' Summer Conference 2026 is expected to generate significant interest among investors. The company's strong financial performance, coupled with its strategic initiatives to expand its market share, positions it for continued success. As the conference approaches, industry watchers will be keenly observing Novanta's presentation for insights into its future plans and growth prospects.

In conclusion, Novanta's participation in the CJS Securities' Summer Conference 2026 is a significant event that highlights the company's leadership in the precision technology sector. With its innovative solutions and strategic growth plans, Novanta is set to shine at this prestigious event, reinforcing its position as a trusted partner to medical and advanced technology equipment manufacturers.